Enzymes, particularly those in the Cytochrome P450 family, are central to metabolic interactions. These enzymes are responsible for the oxidative metabolism of many drugs. Induction or inhibition of these enzymes by certain compounds can significantly alter the metabolism of co-administered drugs. For example, CYP3A4 is a common target for such interactions due to its role in metabolizing a wide variety of substances.
